Huang J.-H.RON-BIN HSU2020-03-102020-03-1020080036-5548https://www.scopus.com/inward/record.uri?eid=2-s2.0-47349124282&doi=10.1080%2f00365540701837126&partnerID=40&md5=ff8cd45c0e644dcdab8848e327d3ef0dhttps://scholars.lib.ntu.edu.tw/handle/123456789/474944[SDGs]SDG3amikacin; cefazolin; cefmetazole; ceftazidime; ceftriaxone; ciprofloxacin; fluconazole; ganciclovir; gentamicin; imipenem; metronidazole; oxacillin; rifampicin; teicoplanin; vancomycin; adult; aged; article; bacteremia; bacterial endocarditis; blood culture; clinical article; controlled study; drug blood level; drug eruption; drug fever; drug substitution; drug withdrawal; female; hospital infection; human; kidney failure; leukopenia; male; methicillin resistant Staphylococcus aureus; monotherapy; mortality; nonhuman; prosthesis infection; retrospective study; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Endocarditis; Female; Hospitals; Humans; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Taiwan; Teicoplanin; Treatment Outcome; Vancomycinjournal article10.1080/00365540701837126185845322-s2.0-47349124282